Prevalence on Musculoskeletal Disorders among Post Covid-19 Patients in Bengaluru
Authors
-
Department of Physiotherapy, Krupanidhi College of Physiotherapy, Bengaluru, Karnataka ,IN
Shaik Mujahid -
Department of Physiotherapy, Krupanidhi College of Physiotherapy, Bengaluru, Karnataka ,INSudhakar Subramanian
DOI:
https://doi.org/10.18311/jeoh/2022/31948Keywords:
Covid-19, Lifestyle Disorder, Muscle Fatigue, Musculoskeletal Disorder, MyalgiaAbstract
Background: Corona virus is infection related with novel COVID strain. The first case was diagnosed in Wuhan city, China. Due to rapid transmission rate an associated complication such as ARDS, pneumonia, shock, respiratory failure and death, in 2019 outbreak of severe ARDS COVID virus causing COVID-19 has global concern. Lack of sleep, Vision impairment, muscle atony are the signs and symptoms in patients whose nervous system and musculoskeletal system is affected thus, identifying the symptoms related to musculoskeletal disorders will help to provide better diagnosis for patients of COVID- 19 and will help to improve the line of treatment. Objective: To determine the prevalence of musculoskeletal disorders in both male and female COVID-19 patients, as well as the relationship between epidemiological determinants of musculoskeletal disorder status in COVID-19 patients. Design: Comparative Cross-Sectional study. Method: After obtaining the consent form from all the patients, Cornell Musculoskeletal Discomfort Questionnaire (CMDQ) was given. Data were examined using Descriptive analysis (SPSS). Result: The result shows that highest prevalence of musculoskeletal disorder was found in Low back region i.e. 54% as compared to other regions of body which were affected due to COVID-19. The prevalence was found to more in female i.e. (61%) as compared to male i.e. (39%). The prevalence among the patients who recovered from hospitalization was more i.e. (52.9%) as compared to the individuals who benefited from home quarantine i.e. (47.1%). Patients who had received both doses of the vaccine had a higher prevalence of the condition i.e. (52%) as compared to the patients who took only one dose of vaccine i.e. (48%). The prevalence was more among the patients who had not taken the steroids i.e. (51.1%) as compared to who had taken steroids i.e. (48.9%). Conclusion: The study concluded that more Female were affected as compared to men and in patients with post COVID-19 low back was commonly affected in comparison from other regions of body.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Shaik Mujahid, Sudhakar Subramanian
This work is licensed under a Creative Commons Attribution 4.0 International License.
Accepted 2023-02-01
Published 2023-03-27
References
Abdullahi A, Candan SA, Abba MA, Bello AH, Alshehri MA, Afamefuna Victor E, UmarNA and Kundakci B. Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis. Frontiers in neurology. 2020; 11:687.
Yuki K, Fujiogi M and Koutsogiannaki S. COVID-19 pathophys¬iology: A review. Clinical immunology. 2020; 215:108427.
Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, Toresdahl BG, Rodeo SA, Casey EK and Mendias CL. Musculoskeletal consequences of COVID-19. JBJS. 2020; 102(14):1197-204.
Batur EB, Korez MK, Gezer IA, Levendoglu F and Ural O. Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. International Journal of Clinical Practice. 2021; 75(6):e14135.
Jain VK, Iyengar KP, Upadhyaya GK, Vaishya R, Nune A. Nonoperative Strategies to Manage Pain in Osteoarthritis dur¬ing COVID-19 Pandemic. Journal of Clinical and Diagnostic Research. 2020; 14(11).
Cares-Marambio K, Montenegro-Jimenez Y, Torres-Castro R, Vera-Uribe R, Torralba Y, Alsina-Restoy X, Vasconcello-Castillo L and Vilaro J. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID- 19): A systematic review and meta-analysis. Chronic respiratory disease. 2021; 18:14799731211002240.
Li H, Wang S, Zhong F, Bao W, Li Y, Liu L, Wang H and He Y. Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China.Frontiers in medicine. 2020; 7:190.
Smith TO, Belderson P, Dainty JR, et al. Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: A mixed- methods study. BMJ Open. 2021; 11:e048772
Luan HD, Hai NT, Xanh PT, Giang HT, Van Thuc P, Hong NM and Khue PM. Musculoskeletal disorders: prevalence and associated factors among district hospital nurses in Haiphong, Vietnam. BioMed research international. 2018; 2018.
Gilbert AW, Booth G, Betts T and Goldberg A. A mixed-methods survey to explore issues with virtual consultations for musculoskeletal care during the COVID-19 pandemic. BMC Musculoskeletal Disorders. 2021; 22(1):1-0.
Batur EB, Korez MK, Gezer IA, Levendoglu F and Ural O. Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. International Journal of Clinical Practice. 2021; 75(6):e14135.
Keavy R. The prevalence of musculoskeletal presentations in gen¬eral practice: an epidemiological study. British Journal of General Practice. 2020; 70(suppl 1).
Vaishya R, Vaish A and Kumar A. Impact of COVID-19 on the practice of orthopaedics and trauma—an epidemiological study of the full pandemic year of a tertiary care centre of New Delhi. International orthopaedics. 2021; 45(6):1391-7.
Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients.
Afifehzadeh-Kashani H, Choobineh A, Bakand S, Gohari MR, Abbastabar H, Moshtaghi P. Validity and reliability of farsi ver¬sion of Cornell Musculoskeletal Discomfort Questionnaire (CMDQ).
Shariat A, Cleland JA, Danaee M, Kargarfard M, Moradi V and Tamrin SB. Relationships between cornell musculoskeletal dis¬comfort questionnaire and online rapid office strain assessment questionnaire. Iranian journal of public health. 2018; 47(11):17.
Jafari-Nodoushan A and Bagheri G. Effect of COVID-19 virus on Prevalence of Musculoskeletal Disorders of Faculty Members of Yazd University. Iranian Journal of Ergonomics. 2020; 8(3):1-2.
Garcia-Sailirrosas EE and Sanchez-Poma RA. Prevalence of Musculoskeletal disorders in University teachers who peform tele network in COVID-19 times. 2020
Karaarslan F, Demircioglu Guneri F, Kardes S. Postdischarge rheumatic and musculoskeletal symptoms following hospitaliza¬tion for COVID-19: prospective followup by phone interviews. Rheumatology international. 2021; 41(7):1263-71.
Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S and Elvers KT. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021; 76(4):399-401.
Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E and Corre F. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection. 2020; 81(6):e4-6.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y and Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus– infected pneumonia in Wuhan, China. Jama. 2020; 323(11):1061- 9.
Wang L, He W, Yu X, Hu D, Bao M, Liu H, Zhou J and Jiang H. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. Journal of Infection. 2020; 80(6):639-45.
Fang D, Ma J, Guan J, Wang M, Song Y, Tian D and Li P. Manifestations of digestive system of hospitalized patients with coronavirus disease 2019 in Wuhan, China: a single- center descriptive study. Chinese Journal of Digestion. 2020:151-6.
Jimeno-Almazan A, Pallares JG, Buendia-Romero A, Martinez- Cava A, Franco- Lopez F, Sanchez-Alcaraz Martinez BJ, Bernal-Morel E and Courel-Ibanez J. Post- COVID-19 syndrome andthe potential benefits of exercise. International journal of environmental research and public health. 2021; 18(10):5.
